ArticlePediatric nephrology (Berlin, Germany)2022

Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study.

Marina Vivarelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.